NO20082005L - Syntese av renininhibitorer omfattende en cyklotilfoyelsesreaksjon - Google Patents

Syntese av renininhibitorer omfattende en cyklotilfoyelsesreaksjon

Info

Publication number
NO20082005L
NO20082005L NO20082005A NO20082005A NO20082005L NO 20082005 L NO20082005 L NO 20082005L NO 20082005 A NO20082005 A NO 20082005A NO 20082005 A NO20082005 A NO 20082005A NO 20082005 L NO20082005 L NO 20082005L
Authority
NO
Norway
Prior art keywords
synthesis
renin inhibitors
cyclot
addition reaction
compound
Prior art date
Application number
NO20082005A
Other languages
English (en)
Norwegian (no)
Inventor
Wolfgang Marterer
Stuart John Mickel
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35394904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20082005(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20082005L publication Critical patent/NO20082005L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/24Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
NO20082005A 2005-09-28 2008-04-28 Syntese av renininhibitorer omfattende en cyklotilfoyelsesreaksjon NO20082005L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0519764.5A GB0519764D0 (en) 2005-09-28 2005-09-28 Organic compounds
PCT/EP2006/009323 WO2007039183A1 (en) 2005-09-28 2006-09-26 Sythesis of renin inhibitors involving a cycloaddition reaction

Publications (1)

Publication Number Publication Date
NO20082005L true NO20082005L (no) 2008-06-24

Family

ID=35394904

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082005A NO20082005L (no) 2005-09-28 2008-04-28 Syntese av renininhibitorer omfattende en cyklotilfoyelsesreaksjon

Country Status (27)

Country Link
US (2) US7973175B2 (es)
EP (2) EP2287153A1 (es)
JP (1) JP2009509990A (es)
KR (1) KR20080048042A (es)
CN (1) CN101273012A (es)
AR (1) AR057137A1 (es)
AT (1) ATE492533T1 (es)
AU (1) AU2006299097B2 (es)
BR (1) BRPI0616707A2 (es)
CA (1) CA2623495A1 (es)
DE (1) DE602006019114D1 (es)
EC (1) ECSP088319A (es)
ES (1) ES2358536T3 (es)
GB (1) GB0519764D0 (es)
GT (1) GT200600427A (es)
IL (1) IL189763A0 (es)
MA (1) MA29852B1 (es)
MY (1) MY143251A (es)
NO (1) NO20082005L (es)
NZ (1) NZ566429A (es)
PE (1) PE20070488A1 (es)
PL (1) PL1931629T3 (es)
PT (1) PT1931629E (es)
RU (1) RU2423348C2 (es)
TN (1) TNSN08142A1 (es)
TW (1) TW200730480A (es)
WO (1) WO2007039183A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2062874B1 (en) 2007-11-20 2014-12-17 KRKA, tovarna zdravil, d.d., Novo mesto Process and intermediates for the preparation of aliskiren
SI2189442T1 (sl) 2008-11-20 2015-03-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek in intermediati za pripravo aliskirena
WO2011051853A1 (en) 2009-10-29 2011-05-05 CarboDesign LLC Manufacturing process for preparing enaniomerically pure 8- aryloctanoic acid derivatives such as aliskiren
CN101863796B (zh) * 2010-05-12 2011-08-24 海南美兰史克制药有限公司 一种阿利克仑化合物及其制法
EP2551260A1 (en) 2011-07-28 2013-01-30 Chemo Ibérica, S.A. Chemical process for opening ring compounds
US8703976B2 (en) 2011-10-02 2014-04-22 Milan Soukup Manufacturing process for 8-aryloctanoic acids such as Aliskiren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421295A1 (de) 1984-06-08 1985-12-12 Basf Ag, 6700 Ludwigshafen Neue pyrrolidincarbonsaeurederivative, verfahren zu ihrer herstellung
MY119161A (en) 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
DE60138099D1 (de) 2000-07-05 2009-05-07 Speedel Pharma Ag Verfahren zur herstellung von substituierten octanoyl-amiden
DE10116816A1 (de) * 2001-04-04 2002-10-17 Basf Ag Verfahren zur Herstellung von N-Benzylaminen
GB0419361D0 (en) 2004-08-31 2004-10-06 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
EP1931629A1 (en) 2008-06-18
GB0519764D0 (en) 2005-11-09
TW200730480A (en) 2007-08-16
ATE492533T1 (de) 2011-01-15
PL1931629T3 (pl) 2011-05-31
RU2008116317A (ru) 2009-11-10
RU2423348C2 (ru) 2011-07-10
CA2623495A1 (en) 2007-04-12
JP2009509990A (ja) 2009-03-12
AU2006299097B2 (en) 2010-11-04
AU2006299097A1 (en) 2007-04-12
EP2287153A1 (en) 2011-02-23
PT1931629E (pt) 2011-03-09
MA29852B1 (fr) 2008-10-03
ECSP088319A (es) 2008-04-28
DE602006019114D1 (de) 2011-02-03
US7973175B2 (en) 2011-07-05
CN101273012A (zh) 2008-09-24
EP1931629B1 (en) 2010-12-22
US20110230665A1 (en) 2011-09-22
MY143251A (en) 2011-04-15
PE20070488A1 (es) 2007-06-13
BRPI0616707A2 (pt) 2011-06-28
IL189763A0 (en) 2008-08-07
WO2007039183A1 (en) 2007-04-12
NZ566429A (en) 2010-10-29
AR057137A1 (es) 2007-11-21
GT200600427A (es) 2007-04-30
US20080255369A1 (en) 2008-10-16
ES2358536T3 (es) 2011-05-11
TNSN08142A1 (en) 2009-07-14
KR20080048042A (ko) 2008-05-30

Similar Documents

Publication Publication Date Title
NO20082263L (no) Organiske forbindelser
NO20080080L (no) Organiske forbindelser
WO2007091009A3 (en) Preparation of delmopinol
NO20074093L (no) Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav
TN2009000401A1 (en) New methods
NO20082005L (no) Syntese av renininhibitorer omfattende en cyklotilfoyelsesreaksjon
CA2665931C (en) Hydrobenzamide derivatives as inhibitors of hsp90
DE602006008962D1 (de) Verfahren zur herstellung von valsartan
WO2008155338A3 (en) Process for the synthesis of intermediates of renin inhibitors such as aliskiren
NO20063268L (no) Fremgangsmate til fremstilling av 1-(2S,3S)-2-benzhydryl-N-(5-tert-butyl-2-metoksybenzyl)quinuklidin-3-amin
WO2005005389A3 (en) Malonamide derivatives
WO2006066044A3 (en) Processes for producing 4-aminoquinazolines
NO20080468L (no) Diazepinokinoliner, synteser av disse samt intermediater
NO20076000L (no) Aminosyrederivater
NO20055657L (no) Nye bioisostaererav aktinonin
WO2009127949A8 (en) 4- [3- (aryloxy) benzylidene] -3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors
NO20065789L (no) Cinnamidforbindelse
WO2005054175A3 (en) New process for the preparation of nitrooxyderivatives of paracetamol
WO2006122072A3 (en) Processes for preparing biaryl ureas and analogs thereof
EP1857435A3 (en) A process for the preparation of aryloxypropylamines
TH88107B (th) สารประกอบอินทรีย์
NO20075700L (no) (+)- og (-)-8-alkyl-3-(trifluoralkylsulfonyloksy)-8-azabisyklo(3.2.1)okt-2-en
WO2010004269A3 (en) Stereospecific synthesis of iduronic acid derivatives, deoxynojirimycin and deoxyidonojirimycin
TH89325B (th) สารประกอบอินทรีย์
WO2004069790A3 (en) Crystalline modifications of triazinylaminostilbenes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application